In support of our results, Nam and colleagues similarly reported a strong decreased expression of Sp1 after CD44 silencing in MDA-MB-231 and Hs578T breast tumor cells, that was associated with decreased migratory/invasive properties [42]. Here, CD44 is linked to breast neoplasm.